Form D · Pharmaceuticals
Exodos Life Sciences Limited Partnership
Chapel Hill, NC · CIK 0001534082
Offering snapshot reported Mar 12, 2014 · SEC filing
- Reported sold
- $688K Offering amount: $1M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 4, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 12, 2014 | Initial | $688,249 | No comparison | 6 | SEC filing |
| Nov 30, 2011 | Amendment | $760,550 | $510,550vs Nov 17, 2011 | 14 | SEC filing |
| Nov 17, 2011 | Initial | $250,000 | No comparison | 14 | SEC filing |
| Nov 4, 2011 | Initial | $1,000,000 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-213430
Source: Form D, filed Mar 12, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William Dickie | Director |
| Crist J. Frangakis | Director |
| Jerry Rosenblatt | Director |
| Ron Vered | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
6340 Quadrangle Drive Suite 120
Chapel Hill, NC, 27517
Chapel Hill, NC, 27517